Jianbo Liu

Jianbo Liu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
SKSuliman Khan
Suliman Khan
LJL. Jun
L. Jun
NANawsherwan
Nawsherwan
RSR. Siddique
R. Siddique
YLY. Li
Y. Li
JLJianbo Liu
Jianbo Liu

24 October 2023 in Science China Chemistry
Verified
Journal Article
Closed access
PDF file
MGMeijia Gu
Meijia Gu
LCLuojia Chen
Luojia Chen
RHRui Hu
Rui Hu
QCQingrong Chen
Qingrong Chen
JLJianbo Liu
Jianbo Liu
SCShi Chen
Shi Chen

13 December 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
SKSuliman Khan
Suliman Khan
RSRabeea Siddique
Rabeea Siddique
WXWang Xiaoyan
Wang Xiaoyan
RZRuiyi Zhang
Ruiyi Zhang
GNGhulam Nabi
Ghulam Nabi
MXMengzhou Xue
Mengzhou Xue
Background: Anxiety and stress like mental illnesses are the common outcomes of viral epidemics and pandemics. Novel coronavirus disease 2019 (COVID‐19) outbreak caused by the severe acute respiratory syndrome coronavirus virus 2 (SARS‐CoV‐2) was first reported in Wuhan, China, and then spread all over the world in a short time.Objectives: To highlight and discuss the impact of COVID‐19 pandemic on mental or psychological health.Method: Literature search and collection of the information were performed using PubMed, the reports from the World health organization, and the Center for disease control and prevention.Results: COVID‐19 infection has already been declared as a global pandemic, which in association with infodemic has increased the risk of psychiatric/psychological disorders. A large population of the world is prone to develop anxiety, depressive disorders, and other mental abnormalities. Therefore, timely psychological interventions and preventive strategies are required. Moreover, the infection has been reported to be linked with cerebrovascular conditions; therefore, patients with underlying cerebrovascular diseases should be given attention.Conclusion: COVID‐19‐mediated mental health complications and cerebrovascular conditions may cause a huge burden on healthcare communities in the future. Therefore, timely intervention and the development or application of preventive strategies are required to decrease the risk of neurological consequences.

4 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XXXia Xue
Xia Xue
JSJianxiang Shi
Jianxiang Shi
HXHongen Xu
Hongen Xu
YQYaping Qin
Yaping Qin
ZYZengguang Yang
Zengguang Yang
JLJianbo Liu
Jianbo Liu
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus causing the COVID-19 pandemic in 2020. High adaptive plasticity on the spike protein of SASR-CoV-2 enables it to transmit across different host species. In the present study, we collected 2092 high-quality genome sequences of SARS-CoV-2 from 160 regions in over 50 countries and reconstructed their phylogeny. We also analyzed the polymorphic interaction between spike protein and human ACE2 (hACE2). Phylogenetic analysis of SARS-CoV-2 suggests that SARS-CoV-2 is probably originated from a recombination event on the spike protein between a bat coronavirus and a pangolin coronavirus that endows it humans infectivity. Compared with other regions in the S gene of SARS-CoV-2, the direct-binding sites of the receptor-binding domain (RBD) is more conserved. We focused on 3,860 amino acid mutations in spike protein RBD (T333-C525) of SARS-CoV-2 and simulated their differential stability and binding affinity to hACE2 (S19-D615). The results indicate no preference for SARS-CoV-2 infectivity on people of different ethnic groups. The variants in the spike protein of SARS-CoV-2 may also be a good indicator demonstrating the transmission route of SARS-CoV-2 from its natural reservoir to human hosts.

1 September 2017 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
XHXiao-Peng Han
Xiao-Peng Han
DLDai-Jian Liu
Dai-Jian Liu
YLYing-Li Liu
Ying-Li Liu
JLJianbo Liu
Jianbo Liu

27 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
XXXia Xue
Xia Xue
JSJianxiang Shi
Jianxiang Shi
HXhongen xu
hongen xu
YQYaping Qin
Yaping Qin
ZYZengguang Yang
Zengguang Yang
JLJianbo Liu
Jianbo Liu
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel coronavirus causing an outbreak of COVID-19 globally in the past six months. A relatively higher divergence on the spike protein of SASR-CoV-2 enables it to transmit across species efficiently. We particularly believe that the adaptive mutations of the receptor-binding domain (RBD) of spike protein in SARS-CoV-2 might be essential to its high transmissibility among humans. Thus here we collected 2,142 high-quality genome sequences of SARS-CoV-2 from 160 regions in over 50 countries and reconstructed their phylogeny, and also analyzed the interaction between the polymorphisms of spike protein and human ACE2 (hACE2). Phylogenetic analysis of SARS-CoV-2 and coronavirus in other hosts show SARS-CoV-2 is highly possible originated from Bat-CoV (RaTG13) found in horseshoe bat and a recombination event may occur on the spike protein of Pangolin-CoV to imbue it the ability to infect humans. Moreover, compared to the S gene of SARS-CoV-2, it is more conserved in the direct-binding sites of RBD and we noticed that spike protein of SARS-CoV-2 may under a consensus evolution to adapt to human hosts better. 3,860 amino acid mutations in spike protein RBD (T333-C525) of SARS-CoV-2 were simulated and their stability and affinity binding to hACE2 (S19-D615) were calculated. Our analysis indicates SARS-CoV-2 could infect humans from different populations with no preference, and a higher divergence in the spike protein of SARS-CoV-2 at the early stage of this pandemic may be a good indicator that could show the pathway of SARS-CoV-2 transmitting from the natural reservoir to human beings.